BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23605565)

  • 1. ALK rearrangement in a pure squamous cell carcinoma: the challenge of detection of ALK rearrangement.
    Kim H; Park E; Kim YJ; Chung JH
    Virchows Arch; 2013 May; 462(5):597-9. PubMed ID: 23605565
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
    Fang F; Wang YX; Hu ST; Yang L; Di J; Liu DG; Lyu N
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):432-437. PubMed ID: 29886587
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of ALK protein expression in lung squamous cell carcinomas by immunohistochemistry.
    Wang J; Shen Q; Shi Q; Yu B; Wang X; Cheng K; Lu G; Zhou X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):109. PubMed ID: 25527865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
    Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH
    J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma.
    Chaft JE; Rekhtman N; Ladanyi M; Riely GJ
    J Thorac Oncol; 2012 Apr; 7(4):768-9. PubMed ID: 22425930
    [No Abstract]   [Full Text] [Related]  

  • 6. ALK-Rearranged Squamous Cell Carcinoma of the Lung Treated with Two Lines of ALK Inhibitors.
    Bolzacchini E; Tuzi A; Pinotti G
    J Thorac Oncol; 2017 May; 12(5):e55-e57. PubMed ID: 28434517
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaplastic lymphoma kinase gene rearrangement in non-small-cell lung cancer in a Brazilian population.
    Lopes LF; Bacchi CE
    Clinics (Sao Paulo); 2012 Jul; 67(7):845-7. PubMed ID: 22892933
    [No Abstract]   [Full Text] [Related]  

  • 8. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM; Erdogan S; Vasmatzis G; Yang P; Tillmans LS; Johnson MR; Wang X; Peterson LM; Halling KC; Oliveira AM; Aubry MC; Yi ES
    Hum Pathol; 2009 Aug; 40(8):1152-8. PubMed ID: 19386350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of anaplastic lymphoma kinase gene rearrangement in non-small-cell lung carcinomas: a comparative study between small biopsy and excision samples.
    Abe H; Kawahara A; Azuma K; Taira T; Takase Y; Fukumitsu C; Murata K; Yamaguchi T; Akiba J; Ishii H; Okamoto I; Hoshino T; Takamori S; Kage M
    J Thorac Oncol; 2015 May; 10(5):800-805. PubMed ID: 25898958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
    Proietti A; Alì G; Pelliccioni S; Lupi C; Sensi E; Boldrini L; Servadio A; Chella A; Ribechini A; Cappuzzo F; Miccoli M; Fontanini G
    Cancer Cytopathol; 2014 Jun; 122(6):445-53. PubMed ID: 24648382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
    Paik JH; Choe G; Kim H; Choe JY; Lee HJ; Lee CT; Lee JS; Jheon S; Chung JH
    J Thorac Oncol; 2011 Mar; 6(3):466-72. PubMed ID: 21258247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma.
    Ying J; Guo L; Qiu T; Shan L; Ling Y; Liu X; Lu N
    Ann Oncol; 2013 Oct; 24(10):2589-2593. PubMed ID: 23904459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed.
    Camidge DR; Kono SA; Lu X; Okuyama S; Barón AE; Oton AB; Davies AM; Varella-Garcia M; Franklin W; Doebele RC
    J Thorac Oncol; 2011 Apr; 6(4):774-80. PubMed ID: 21336183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent.
    Conklin CM; Craddock KJ; Have C; Laskin J; Couture C; Ionescu DN
    J Thorac Oncol; 2013 Jan; 8(1):45-51. PubMed ID: 23196275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALK translocation in non-small cell lung cancer with adenocarcinoma and squamous cell carcinoma markers.
    Klempner SJ; Cohen DW; Costa DB
    J Thorac Oncol; 2011 Aug; 6(8):1439-40. PubMed ID: 21847065
    [No Abstract]   [Full Text] [Related]  

  • 16. ALK-rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?
    Vergne F; Quéré G; Andrieu-Key S; Descourt R; Quintin-Roué I; Talagas M; De Braekeleer M; Marcorelles P; Uguen A
    Lung Cancer; 2016 Jan; 91():67-9. PubMed ID: 26603857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of ALK rearrangement in an octogenarian patient with pleomorphic carcinoma of the lung.
    Maruyama R; Matsumura F; Shibata Y; Takahashi H; Okabayashi H; Kosai S; Honda I; Ohkawara S; Sugimoto M
    Gen Thorac Cardiovasc Surg; 2016 Mar; 64(3):167-9. PubMed ID: 24846683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancer.
    Nicoś M; Jarosz B; Krawczyk P; Wojas-Krawczyk K; Kucharczyk T; Sawicki M; Pankowski J; Trojanowski T; Milanowski J
    Brain Pathol; 2018 Jan; 28(1):77-86. PubMed ID: 27879019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer and related issues in ALK inhibitor therapy: a literature review.
    Yi ES; Chung JH; Kulig K; Kerr KM
    Mol Diagn Ther; 2012 Jun; 16(3):143-50. PubMed ID: 22506598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.
    Cha YJ; Kim HR; Shim HS
    J Transl Med; 2016 Oct; 14(1):296. PubMed ID: 27756333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.